| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2543863 | Journal of the American Pharmacists Association | 2013 | 9 Pages |
Abstract
Nearly one-half of community-dwelling older adults had a clinically relevant ACB score of 3 or greater. The ACB score could be used as a component of MTM services in a variety of practice settings to identify older adults who are at higher risk for potential central and peripheral adverse effects related to cumulative anticholinergic activity of their medications. Additional research to measure the clinical impact of ACB assessment and modification is needed.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Teri PharmD, BCPS, Maria C. (Associate Professor of Clinical Pharmacy), Kyle MAS, Ruth (Clinical Assistant Professor),